Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy

Lade...
Vorschaubild
Dateien
Kendel_2-k0rcopkzocm71.pdf
Kendel_2-k0rcopkzocm71.pdfGröße: 205.68 KBDownloads: 2
Datum
2016
Autor:innen
Kendel, Friederike
Helbig, Lukas
Neumann, Konrad
Herden, Jan
Stephan, Carsten
Schrader, Mark
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
ArXiv-ID
Internationale Patentnummer
Link zur Lizenz
oops
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
International Journal of Cancer. Wiley. 2016, 139(4), pp. 749-753. ISSN 0020-7136. eISSN 1097-0215. Available under: doi: 10.1002/ijc.30123
Zusammenfassung

Treatment choice for localized prostate cancer (PCa) is a controversial issue, and mortality risk is probably the most decisive factor in this regard. The study aimed to compare prostate-cancer-specific mortality risk estimates for different treatment options assigned by patients managed with active surveillance (AS), radical prostatectomy (RP), and patients who had discontinued AS (DAS). We matched patients initially managed with AS or RP (N = 370) according to length of therapy. Patients completed mailed questionnaires assessing their mortality risk estimates (in %) and prostate-cancer-specific anxiety. We analyzed differences in risk estimates among the three treatment groups using ANOVA, relationships of clinical and psychosocial variables with risk estimates using standard multiple regression. In all treatment groups, the prostate- cancer-specific mortality risk was overestimated. This applied whether it was the patient's own treatment or the alternative treatment option. RP patients assigned a mortality risk to AS that was almost three times higher than that assigned to RP (50.9±25.0 vs. 17.8±19.7, d = 1.48; p <.001). Anxiety was significantly associated with risk estimates for AS (p = .008) and RP (p = .001). Compared to clinical data that suggest that the prostate-cancer-specific mortality risk for AS is low and does not significantly differ from that for RP, patients strongly overestimated the mortality risk. This was most markedly so in RP patients, who drastically overestimated the benefits of RP compared to the risk of AS. This overestimation could increase overtreatment and should therefore be corrected by better patient education. This article is protected by copyright. All rights reserved.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
150 Psychologie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690KENDEL, Friederike, Lukas HELBIG, Konrad NEUMANN, Jan HERDEN, Carsten STEPHAN, Mark SCHRADER, Wolfgang GAISSMAIER, 2016. Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy. In: International Journal of Cancer. Wiley. 2016, 139(4), pp. 749-753. ISSN 0020-7136. eISSN 1097-0215. Available under: doi: 10.1002/ijc.30123
BibTex
@article{Kendel2016-08-15Patie-34167,
  year={2016},
  doi={10.1002/ijc.30123},
  title={Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy},
  number={4},
  volume={139},
  issn={0020-7136},
  journal={International Journal of Cancer},
  pages={749--753},
  author={Kendel, Friederike and Helbig, Lukas and Neumann, Konrad and Herden, Jan and Stephan, Carsten and Schrader, Mark and Gaissmaier, Wolfgang}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/34167">
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/34167"/>
    <dc:creator>Kendel, Friederike</dc:creator>
    <dc:creator>Herden, Jan</dc:creator>
    <dc:creator>Schrader, Mark</dc:creator>
    <dc:contributor>Stephan, Carsten</dc:contributor>
    <dc:contributor>Helbig, Lukas</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Kendel, Friederike</dc:contributor>
    <dcterms:abstract xml:lang="eng">Treatment choice for localized prostate cancer (PCa) is a controversial issue, and mortality risk is probably the most decisive factor in this regard. The study aimed to compare prostate-cancer-specific mortality risk estimates for different treatment options assigned by patients managed with active surveillance (AS), radical prostatectomy (RP), and patients who had discontinued AS (DAS). We matched patients initially managed with AS or RP (N = 370) according to length of therapy. Patients completed mailed questionnaires assessing their mortality risk estimates (in %) and prostate-cancer-specific anxiety. We analyzed differences in risk estimates among the three treatment groups using ANOVA, relationships of clinical and psychosocial variables with risk estimates using standard multiple regression. In all treatment groups, the prostate- cancer-specific mortality risk was overestimated. This applied whether it was the patient's own treatment or the alternative treatment option. RP patients assigned a mortality risk to AS that was almost three times higher than that assigned to RP (50.9±25.0 vs. 17.8±19.7, d = 1.48; p &lt;.001). Anxiety was significantly associated with risk estimates for AS (p = .008) and RP (p = .001). Compared to clinical data that suggest that the prostate-cancer-specific mortality risk for AS is low and does not significantly differ from that for RP, patients strongly overestimated the mortality risk. This was most markedly so in RP patients, who drastically overestimated the benefits of RP compared to the risk of AS. This overestimation could increase overtreatment and should therefore be corrected by better patient education. This article is protected by copyright. All rights reserved.</dcterms:abstract>
    <dc:contributor>Neumann, Konrad</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-06-01T08:19:06Z</dcterms:available>
    <dc:contributor>Schrader, Mark</dc:contributor>
    <dc:creator>Stephan, Carsten</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dc:contributor>Herden, Jan</dc:contributor>
    <dc:creator>Gaissmaier, Wolfgang</dc:creator>
    <dcterms:title>Patients' perceptions of mortality risk for localized prostate cancer vary markedly depending on their treatment strategy</dcterms:title>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/34167/1/Kendel_2-k0rcopkzocm71.pdf"/>
    <dc:creator>Helbig, Lukas</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/34167/1/Kendel_2-k0rcopkzocm71.pdf"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-06-01T08:19:06Z</dc:date>
    <dc:creator>Neumann, Konrad</dc:creator>
    <dc:contributor>Gaissmaier, Wolfgang</dc:contributor>
    <dc:language>eng</dc:language>
    <dcterms:issued>2016-08-15</dcterms:issued>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen